FARALLON CAPITAL PARTNERS LP 13D/13G Filings for Better Therapeutics, Inc. (BTTX)

FARALLON CAPITAL PARTNERS LP 13D and 13G filings for Better Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-07
5:10 pm
Sale
2022-12-3113GBetter Therapeutics, Inc.
BTTX
FARALLON CAPITAL PARTNERS LP813,556
3.400%
-536,444decrease
(-39.74%)
Filing
2021-11-08
1:11 pm
Purchase
2021-10-2813GBetter Therapeutics, Inc.
BTTX
FARALLON CAPITAL PARTNERS LP1,350,000
5.700%
1,350,000increase
(New Position)
Filing